Ewelina Weglarz-Tomczak (UvA): Lysosomal protease inhibitors for Alzheimer’s
Ewelina Weglarz-Tomczak (UvA): Novel lysosomal protease inhibitors for the treatment of Alzheimer’s disease
Highly specified proteases are the key regulators in the molecular mechanism of neurodegeneration in Alzheimer’s disease. AI-powered technology developed by NatInLab has led to the discovery of how those proteases are controlled in the human organism. Based on this knowledge, developing novel, highly effective and safe inhibitors of these proteases is possible. The project aims to deliver new agents against Alzheimer’s and possibly other neurodegenerative diseases as the next step. The novel drugs are expected to be curative and show minimal side effects.
Explore other Cases:
Mădălina Rîurean (VU): Madglove
Mădălina Rîurean (VU): Madglove- helping people get a grasp on spasticity. Over 40 million people in the world struggle with hand spasticity, creating pain and making it difficult for them to do simple daily tasks. Madglove is creating low tech, accessible, home rehabilitation solutions, to give back people their independence. Through co-creation with end users […]
Imran Avci (VU): COMB-O
Imran Avci (VU): Disposable, ultra-sensitive optical biosensors for early cancer diagnosis (COMB-O) In the last decade, cancer has become a silent pandemic as it is the second leading cause of death globally. Early diagnosis is critical for successful treatment, and therefore we urgently need sensitive, specific and affordable solutions. The development of optical biosensors that […]
Siwan Aberkane (VU): PULSE Sports
Siwan Aberkane (VU): PULSE Sports – App-connected sportswear allowing athletes to monitor their body & mind, to maximise performance & avoid over-training. Millions of athletes worldwide are in a crisis, struggling with extreme physical and mental issues. Research experts and athletes themselves confirme that existing tools are too superficial and inaccurate for the prevention of […]